Overview

Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension

Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
This study is to assess the safety and efficacy of an add-on treatment algorithm with olmesartan, hydrochlorothiazide and amlodipine in patients with mild to moderate hypertension.
Phase:
Phase 4
Details
Lead Sponsor:
Sankyo Pharma Gmbh
Treatments:
Amlodipine
Hydrochlorothiazide
Olmesartan
Olmesartan Medoxomil